Product Program year 2025 Source: CMS Open Payments

Embotrap

Device Neurovascular

PDI 10886704084570

Open in the dashboard

General payments

$748,259

4,983 payments

Research payments

$10,247

2 payments

Through program year 2025, $748,259 in general payments and $10,247 in research payments were reported against Embotrap (Neurovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $69,689 858
2025 Research $10,247 2
2024 General $130,380 1,334
2023 General $373,081 1,304
2022 General $107,352 941
2021 General $67,757 546

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $579,664 1,315 payments
  2. DePuy Synthes Sales Inc. $166,807 3,653 payments
  3. Johnson and Johnson International $1,650 13 payments
  4. Biosense Webster, Inc. $138 2 payments
Top recipients General payments · program year 2025
  1. Mohammad Chaudry Neuroradiology · Greenville, SC $22,935 33% · 9 payments
  2. Orlando Diaz Vascular & Interventional Radiology · Houston, TX $2,538 4% · 36 payments
  3. Lucido Ponce Mejia Neurocritical Care · New Orleans, LA $936 1% · 9 payments
  4. Cordell Baker Neurological Surgery · Salt Lake City, UT $713 1% · 2 payments
  5. Matthew Berlet Diagnostic Radiology · Tampa, FL $614 <1% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neuroradiology Radiology $24,823 36% · 23 practitioners
  2. Neurological Surgery $13,401 20% · 96 practitioners
  3. Vascular & Interventional Radiology Radiology $6,643 10% · 37 practitioners
  4. Neurology Psychiatry & Neurology $5,572 8% · 50 practitioners
  5. Vascular Neurology Psychiatry & Neurology $4,832 7% · 39 practitioners

The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. South Carolina $23,929 34% · 17 recipients
  2. Texas $8,236 12% · 42 recipients
  3. Florida $6,039 9% · 42 recipients
  4. California $5,188 7% · 83 recipients
  5. Louisiana $2,651 4% · 17 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,983 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record